Patrick Jackson, Assistant Professor in the Department of Medicine’s division of Infectious Diseases and International Health, has helped care for hundreds of COVID-19 patients and assisted in Paxlovid clinical trials. The Conversation asked him to explain what the drug does and what impact greater availability may have in the fight against the coronavirus. Read the article.
Filed Under: Clinical, Media Highlights